Socioeconomic and insurance‐related disparities in disease‐specific survival among patients with metastatic bone disease

Approximately 5% of cancer patients in the United States presented with metastatic bone disease (MBD) at diagnosis. Current study explores the disparities in survival for patients with MBD.

[1]  B. Pollock,et al.  Sex, racial/ethnic and socioeconomic disparities in patients with metastatic bone disease , 2021, Journal of surgical oncology.

[2]  E. Feletto,et al.  Socioeconomic disparities in colorectal cancer survival: contributions of prognostic factors in a large Australian cohort , 2021, Journal of Cancer Research and Clinical Oncology.

[3]  P. Pierorazio,et al.  Disparities in the Treatment and Survival of Metastatic Renal Cell Carcinoma. , 2021, Urology.

[4]  A. Mavrogenis,et al.  What’s new in the management of metastatic bone disease , 2021, European Journal of Orthopaedic Surgery & Traumatology.

[5]  V. Bouvier,et al.  Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based Study , 2021, Cancers.

[6]  R. Ojha,et al.  Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients. , 2021, Annals of epidemiology.

[7]  A. Mavrogenis,et al.  Current Overview of Treatment for Metastatic Bone Disease , 2021, Current oncology.

[8]  R. Hendrick,et al.  Age distributions of breast cancer diagnosis and mortality by race and ethnicity in US women , 2021, Cancer.

[9]  Sarah E. Seton-Rogers.  Metastases arrive at other organs via bone , 2021, Nature Reviews Cancer.

[10]  Purba Singh,et al.  The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells. , 2021, Developmental cell.

[11]  Siyu Chen,et al.  Sex Disparities in the Clinical Characteristics, Synchronous Distant Metastasis Occurrence and Prognosis: A Pan-cancer Analysis , 2021, Journal of Cancer.

[12]  X. Zhang,et al.  The bone microenvironment invigorates metastatic seeds for further dissemination , 2020, Cell.

[13]  J. Carethers.  Racial and ethnic disparities in colorectal cancer incidence and mortality. , 2021, Advances in cancer research.

[14]  H. Weir,et al.  Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017 , 2020, MMWR. Morbidity and mortality weekly report.

[15]  J. Poynter,et al.  Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis , 2020, JAMA network open.

[16]  A. Mariotto,et al.  Medical Care Costs Associated with Cancer Survivorship in the United States , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[17]  Chuangang Tang,et al.  Incidence, prevalence, and outcomes of systemic malignancy with bone metastases , 2020, Journal of orthopaedic surgery.

[18]  Y. Li,et al.  Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study , 2020, Annals of translational medicine.

[19]  K. Peltzer,et al.  Racial disparities in bone metastasis patterns and targeted screening and treatment strategies in newly diagnosed lung cancer patients , 2020, Ethnicity & health.

[20]  M. Meeus,et al.  Kinesiophobia contributes to pain-related disability in breast cancer survivors: a cross-sectional study , 2020, Supportive Care in Cancer.

[21]  S. Badal,et al.  Disparities in prostate cancer incidence and mortality rates: Solvable or not? , 2019, The Prostate.

[22]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[23]  M. Schabath,et al.  Cancer Progress and Priorities: Lung Cancer , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[24]  Jianjun He,et al.  The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer , 2019, BMC Cancer.

[25]  H. Wong,et al.  Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015 , 2019, Front. Oncol..

[26]  A. Kim,et al.  The effect of socioeconomic status on treatment and mortality in non-small cell lung cancer patients. , 2019, The Annals of thoracic surgery.

[27]  Paul B Tchounwou,et al.  Health and Racial Disparity in Breast Cancer. , 2019, Advances in experimental medicine and biology.

[28]  P. Rosenbaum,et al.  Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance , 2018, The Milbank quarterly.

[29]  H. Brenner,et al.  Socioeconomic Differences and Lung Cancer Survival—Systematic Review and Meta-Analysis , 2018, Front. Oncol..

[30]  M. Dias,et al.  Smoking cessation before initiation of chemotherapy in metastatic non-small cell lung cancer: influence on prognosis , 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[31]  Kevin B. Jones,et al.  PROMIS® scores in operative metastatic bone disease patients: A multicenter, prospective study , 2018, Journal of surgical oncology.

[32]  M. Umer,et al.  Skeletal metastasis in renal cell carcinoma: A review , 2018, Annals of medicine and surgery.

[33]  J. Li,et al.  Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages , 2017, Scientific Reports.

[34]  Purushottam W. Laud,et al.  Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D , 2016, Medical care.

[35]  C. Jackson,et al.  Health disparities in colorectal cancer among racial and ethnic minorities in the United States. , 2016, Journal of gastrointestinal oncology.

[36]  J. Eberth,et al.  Disparities in Breast Cancer Incidence, Mortality, and Quality of Care among African American and European American Women in South Carolina , 2016, Southern medical journal.

[37]  O. von dem Knesebeck,et al.  Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors. , 2015, Social science & medicine.

[38]  B. Snyder,et al.  Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis , 2015, Clinical Cancer Research.

[39]  S. Barni,et al.  Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? , 2015, Journal of Experimental & Clinical Cancer Research.

[40]  T. Klatte,et al.  Gender differences in incidence and outcomes of urothelial and kidney cancer , 2015, Nature Reviews Urology.

[41]  F. Farrokhyar,et al.  Surgical Management of Bone Metastases: Quality of Evidence and Systematic Review , 2014, Annals of Surgical Oncology.

[42]  R. Wedin,et al.  Prognostic role of en‐bloc resection and late onset of bone metastasis in patients with bone‐seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases , 2014, Journal of surgical oncology.

[43]  Facs R. Lor Randall MD.  A Promise to Our Patients with Metastatic Bone Disease , 2014, Annals of Surgical Oncology.

[44]  K. Cronin,et al.  Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data , 2013, Cancer Causes & Control.

[45]  D. Raghavan,et al.  Survival disparities by Medicaid status , 2012, Cancer.

[46]  C. Mullins,et al.  Bone metastasis (BM) based on SEER registry versus Medicare claims among metastatic prostate cancer (PCa) patients (pts) in SEER-Medicare. , 2012 .

[47]  A. Jemal,et al.  Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  R. Coleman,et al.  Bone cancer in 2011: Prevention and treatment of bone metastases , 2012, Nature Reviews Clinical Oncology.

[49]  A. Reyners,et al.  Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life , 2010, Cancer.

[50]  S. Scully,et al.  In Brief: Classifications in Brief: Mirels’ Classification: Metastatic Disease in Long Bones and Impending Pathologic Fracture , 2010, Clinical orthopaedics and related research.

[51]  C. Beauchamp.  Ewing Sarcoma Demonstrates Racial Disparities in Incidence-related and Sex-related Differences in Outcome: An Analysis of 1631 Cases From the SEER Database, 1973-2005 , 2010 .

[52]  L. Koniaris,et al.  Ewing sarcoma demonstrates racial disparities in incidence‐related and sex‐related differences in outcome , 2009, Cancer.

[53]  A. Bleyer.  Young Adult Oncology: The Patients and Their Survival Challenges , 2007, CA: a cancer journal for clinicians.

[54]  K. Schulman,et al.  Economic burden of metastatic bone disease in the U.S. , 2007, Cancer.

[55]  R. Coleman.  Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[56]  F. Sim,et al.  Advances and challenges in diagnosis and management of skeletal metastases. , 2006, Orthopedics.

[57]  W. Wright,et al.  Socioeconomic status and breast cancer incidence in California for different race/ethnic groups , 2001, Cancer Causes & Control.

[58]  Coleman Re.  Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseases. , 2001 .

[59]  D. Campanacci,et al.  The treatment of metastases in the appendicular skeleton. , 2001, The Journal of bone and joint surgery. British volume.

[60]  R. Coleman.  Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseases. , 2001, Cancer treatment reviews.

[61]  A. Aboulafia,et al.  Incidence, location, and diagnostic evaluation of metastatic bone disease. , 2000, The Orthopedic clinics of North America.

[62]  F. Sim,et al.  Surgical Treatment of Metastatic Disease of the Femur , 2000, The Journal of the American Academy of Orthopaedic Surgeons.

[63]  J. Murray,et al.  Surgical management of secondary neoplastic fractures about the hip. , 1974, The Orthopedic clinics of North America.

[64]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.